Literature DB >> 12204431

Quantity of mutant K-ras gene in pancreatic secretions for diagnosis of pancreatic carcinoma with different assays: analysis of 100 patients.

Minoru Tada1, Keisuke Tateishi, Takao Kawabe, Naoki Sasahira, Hiroyuki Isayama, Yutaka Komatsu, Yasushi Shiratori, Masao Omata.   

Abstract

BACKGROUND: Two types of quantitative assay kits for K-ras mutations, PCR-preferential homoduplex formation assay (PHFA) and enriched PCR and enzyme-linked mini-sequence assay (ELMA), were recently developed. The K-ras mutations were analyzed using these assays.
MATERIALS AND METHODS: DNA was extracted from the pancreatic juice which was obtained by endoscopy from 38 patients with pancreatic neoplasms (23 adenocarcinomas and 15 intraductal papillary neoplasms) and from 62 without it.
RESULTS: The results of the two methods were mutually correlative. K-ras mutation was detected at high levels (mutant ras genes occupied >2% of all K-ras genes) in 25 of the 38 cases (66%) with pancreatic neoplasm. It was also detected at high levels in 9 of the 14 cases (64%) with pancreatic cyst. In contrast, the mutant gene was detected at a lower level (<2%) in other cases.
CONCLUSIONS: Quantitative analysis of the mutant ras gene provided a useful tool for diagnosing the pancreatic carcinoma when the percentage of the mutant is high, especially when the types of mutation were either GAT or GTT. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12204431     DOI: 10.1016/s0009-8981(02)00237-1

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  4 in total

1.  Asymptomatic curable pancreatic ductal carcinoma detected during the follow-up of pancreatic cysts distinct from carcinoma.

Authors:  Natsuko Kawada; Hiroyuki Uehara; Kazuhiro Katayama; Sachiko Tanaka; Rena Takakura; Yasuna Takano; Tatsuya Ioka; Miho Nakao; Kazuho Imanaka; Kazuyoshi Ohkawa; Akemi Takenaka; Yasuhiko Tomita; Osamu Ishikawa
Journal:  Clin J Gastroenterol       Date:  2011-03-01

2.  Next generation sequencing improves the accuracy of KRAS mutation analysis in endoscopic ultrasound fine needle aspiration pancreatic lesions.

Authors:  Dario de Biase; Michela Visani; Paola Baccarini; Anna Maria Polifemo; Antonella Maimone; Adele Fornelli; Adriana Giuliani; Nicola Zanini; Carlo Fabbri; Annalisa Pession; Giovanni Tallini
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

3.  K-ras mutation in the endometrium of tamoxifen-treated breast cancer patients, with a comparison of tamoxifen and toremifene.

Authors:  T Hachisuga; H Tsujioka; S Horiuchi; T Udou; M Emoto; T Kawarabayashi
Journal:  Br J Cancer       Date:  2005-03-28       Impact factor: 7.640

Review 4.  K-ras mutational status in cytohistological tissue as a molecular marker for the diagnosis of pancreatic cancer: a systematic review and meta-analysis.

Authors:  Jing Yang; Jingjing Li; Rong Zhu; Huawei Zhang; Yuanyuan Zheng; Weiqi Dai; Fan Wang; Miao Shen; Kan Chen; Ping Cheng; Yan Zhang; Chengfen Wang; Junshan Wang; Yujing Xia; Jie Lu; Yingqun Zhou; Chuanyong Guo
Journal:  Dis Markers       Date:  2014-07-16       Impact factor: 3.434

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.